Tranexamic acid in trauma: we need stronger global health policy.

Alvarado, JC; Dewan, Y; Elsayed, HF; Gogichaishvili, T; Gupta, S; Hunt, B; Iribhogbe, P; Izurieta, M; Khamis, H; Komolafe, EO; +10 more...Mantilla, JHM; Miranda, JORCID logo; Uribe, CHM; Olaomi, O; Olldashi, F; Perel, PORCID logo; Ramana, P; Ravi, R; Roberts, I; Shakur, HORCID logo and (2013) Tranexamic acid in trauma: we need stronger global health policy. BMJ (Clinical research ed), 347 (jul23). f4593-. ISSN 0959-8138 DOI: 10.1136/bmj.f4593
Copy

Tranexamic acid substantially reduces death in bleeding trauma patients. So why are the World Health Organization, the United Nations, the World Bank, and Unicef not ensuring global implementation, ask Ian Roberts and colleagues
Item Type Article
Keywords randomized controlled-trial, transfusion, mortality, crash-2, death, Antifibrinolytic Agents, therapeutic use, Health Policy, trends, Hemorrhage, drug therapy, mortality, Humans, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Survival Rate, Tranexamic Acid, therapeutic use, World Health, trends, Wounds and Injuries, drug therapy, mortality
ISI 322524400006
Date Deposited 23 Sep 2013 19:11

Explore Further

Full text not available from this repository.

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads